AusMedtech Regulatory Affairs Advisory Group
The Advisory Group represents members in the medical technology sector providing guidance and advice to AusBiotech on operational and policy-related regulatory matters regarding dealings with the Therapeutic Goods Administration (TGA). The Advisory Group provides representation through coordination of submissions to the TGA and Department of Health consultations and participation in the TGA/Industry Regulatory and Technical Consultative Forum.
Chaired by Grant Bennett, Chief Executive Officer, Brandwood-CKC.
- Myriam Battistutta, Head of Regulatory, Ellume
- Gary Burgess, Regulatory Affairs Manager APAC, Cochlear Limited
- Dr Darren Forrest, Director of Quality & Regulatory Affairs ANZ, Medtronic Australasia Pty Ltd
- Rebecca Gaudin, Director of Regulatory Affairs, ANZ, Johnson & Johnson Innovation
- Dr Jeremy Paull, VP Development & Regulatory Affairs, Starphama Pty Ltd